FR2382453A1 - Procede pour isoler l'antibiotique thienamycine - Google Patents

Procede pour isoler l'antibiotique thienamycine

Info

Publication number
FR2382453A1
FR2382453A1 FR7805531A FR7805531A FR2382453A1 FR 2382453 A1 FR2382453 A1 FR 2382453A1 FR 7805531 A FR7805531 A FR 7805531A FR 7805531 A FR7805531 A FR 7805531A FR 2382453 A1 FR2382453 A1 FR 2382453A1
Authority
FR
France
Prior art keywords
thienamycin
isolating
gram
antibiotic thienamycin
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7805531A
Other languages
English (en)
Other versions
FR2382453B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2382453A1 publication Critical patent/FR2382453A1/fr
Application granted granted Critical
Publication of FR2382453B1 publication Critical patent/FR2382453B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne l'isolation de la thiénamycine. On isole la thiénamycine, une substance possédant une activité antibiotique contre des micro-organismes Gram-négatifs et Gram-positifs, à partir de bouillons de fermentation ou de solutions impures en utilisant des systèmes liquides d'échange d'ions. Ce procédé permet d'augmenter les rendements de séparation de la thiénamycine.
FR7805531A 1977-03-01 1978-02-27 Procede pour isoler l'antibiotique thienamycine Granted FR2382453A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77335477A 1977-03-01 1977-03-01

Publications (2)

Publication Number Publication Date
FR2382453A1 true FR2382453A1 (fr) 1978-09-29
FR2382453B1 FR2382453B1 (fr) 1982-11-19

Family

ID=25097982

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7805531A Granted FR2382453A1 (fr) 1977-03-01 1978-02-27 Procede pour isoler l'antibiotique thienamycine

Country Status (11)

Country Link
JP (1) JPS53107483A (fr)
CH (1) CH638521A5 (fr)
DE (1) DE2808636A1 (fr)
DK (1) DK144097C (fr)
ES (1) ES467309A1 (fr)
FR (1) FR2382453A1 (fr)
GB (1) GB1568924A (fr)
IT (1) IT1103481B (fr)
NL (1) NL7801756A (fr)
PT (1) PT67721A (fr)
SE (1) SE7801695L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024447B1 (fr) * 1979-08-28 1983-07-20 Merck & Co. Inc. Procédé de purification de la thiénamycine
DE3146190A1 (de) * 1981-11-21 1983-06-16 Hoechst Ag, 6230 Frankfurt Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen

Also Published As

Publication number Publication date
DK144097B (da) 1981-12-07
DK67478A (da) 1978-09-02
CH638521A5 (en) 1983-09-30
NL7801756A (nl) 1978-09-05
IT7848188A0 (it) 1978-02-24
ES467309A1 (es) 1979-08-16
PT67721A (en) 1978-04-01
SE7801695L (sv) 1978-09-02
DE2808636A1 (de) 1978-09-07
FR2382453B1 (fr) 1982-11-19
IT1103481B (it) 1985-10-14
DK144097C (da) 1982-05-17
JPS53107483A (en) 1978-09-19
GB1568924A (en) 1980-06-11

Similar Documents

Publication Publication Date Title
US4141986A (en) Antibiotics 890A2 and 890A5
FR2387984A1 (fr) N-acetyl-dehydro-thienamycine antibiotique
Walker et al. Enzymic Studies on the Biosynthesis of Streptomycin: TRANSAMIDINATION OF INOSAMINE AND STREPTAMINE DERIVATIVES
Okano et al. Stereocontrolled synthesis of an ene-carbapenem antibiotic (-)-asparenomycin C
Sawa et al. Metabolic conversion of formycin B to formycin A and to oxoformycin B in Nocardia interforma
FR2382453A1 (fr) Procede pour isoler l'antibiotique thienamycine
EP0176068A2 (fr) Procédé de préparation des stéréoisomères des acides 1-amino-alkylphosphoniques ou 1-amino-alkylphosphiniques
JPS5758687A (en) Antibiotic
JPS5446887A (en) Preparation of acrylic acid or methacrylic acid
US3718644A (en) Antibiotic separation and purification
EP0046641B1 (fr) Antibiotiques, préparation microbiologique d'antibiotiques et un micro-organisme
Perlman et al. MICROBIAL PRODUCTION OF VITAMIN B12 ANTIMETABOLITES. IN 5-HYDROXY-L-ARGININE FROM BACILLUS CEREUS 439
US4292309A (en) Antibiotics C-14482 B1, B2 and B3
JPS5498741A (en) Novel antibiotic and its preparation
Pruess et al. ANTIMETABOLITES PRODUCED BY MICROORGANISMS. XI. 1) 1-(S)-HYDROXY-2-(S, S)-VALYLAMIDO-CYCLOBUTANE-1-ACETIC ACID
Hayashi et al. Isolation and characterization of mannopeptins, new antibiotics
US4241182A (en) Fortimicin factors KG1, KG2 and KG3 and processes for production thereof
US4508648A (en) Phosphoric ester of antibiotic OA-6129
HUP9902644A2 (hu) Új orthosomycinek Micromonospora carbonacea-ból
Hamblin et al. Mung bean (Phaseolus aureus) nuclease. A mechanistic investigation of the DNA-cleavage reaction using a dinucleoside phosphorothioate
YANO et al. On the enzymic inactivation of dihydrostreptomycin by pseudomonas lachrymans, cucumber angular leaf spot bacterium isolation and structural resolution of the inactivated product
Liu et al. Carbocyclic substrates for de novo purine biosynthesis.
US3092620A (en) Derivatives of penicillanic acid
Basker et al. Comparative biological properties of some synthetic olivanic acid analogues
US4380581A (en) Istamycins and streptomyces culture for the production thereof

Legal Events

Date Code Title Description
ST Notification of lapse